Oxford BioMedica
Ceri Schofield has held various leadership roles in the biopharmaceutical industry, including Vice President and Head of Quality at Oxford Biomedica. Prior to this, Ceri worked at Lonza as Head of Analytical Method Development and Product Characterisation. Additionally, Ceri served as Associate Director at Huntingdon Life Sciences and Head of Contract Research at Maccine Pte Ltd. With a BSc Hons in Biological Sciences from Manchester Metropolitan University, Ceri has extensive experience in quality assurance, analytical services, and bioanalytical research.
This person is not in any offices
Oxford BioMedica
2 followers
Oxford Biomedica (LSE: OXB) is a leading, fully integrated, cell and gene therapy group.